Overall, CD147 appears to be highly correlated with the onset of COVID-19, thereby providing evidence for using CD147 as a new potential therapeutic strategy in the prevention and treatment of SARS-CoV-2 infections in human tissues and organs. Here, BSG is linked to COVID-19.